|

Conditioning Regimen E Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 2: 1

Top Sponsors

  • Center for International Blood and Marrow Transplant Research1

Indications

  • Myeloproliferative Neoplasm (MPN)1
  • Prolymphocyctic Leukemia1
  • CML (Chronic Myelogenous Leukemia)1
  • Acute Leukemia (Category)1
  • Acute Lymphoid Leukemia (ALL)1

Birmingham, Alabama1 trial

A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation

University of Alabama Birmingham

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.